1256450-59-5Relevant articles and documents
RADIOLABELED PDE10 INHIBITORS
-
, (2019/07/13)
The present invention is directed to radiolabeled pyrimidinone compounds of general structural formula I which are useful as radiotracers for quantitative imaging of PDE10 in mammals.
PYRIMIDINONES AS PDE10 INHIBITORS
-
Page/Page column 48-49, (2010/12/26)
The present invention is directed to pyrimidinone compounds of general structural formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10).